Abstract
Abstract Lipoxygenases (LOXs) are iron‐containing enzymes that catalyse the peroxidation of polyunsaturated fatty acids. In mammals, LOX products and their metabolites are potent lipid mediators that provoke diverse biological responses. These eicosanoids, derived from arachidonic acid, play important roles in inflammation and the resolution of inflammation. Moreover, they have been implicated in the development of cardiovascular disease. Although several LOX isoforms are expressed in individual organisms, each generates a specific product. How structurally and mechanistically related enzymes generate different products from a common substrate is not fully understood. In addition, the biological effects of many of the lipid mediators produced through LOX pathways remain to be uncovered. Key Concepts: Arachidonic acid is a substrate for lipoxygenases, iron enzymes that catalyse the peroxidation of polyunsaturated fatty acids. Mammalian lipoxygenases transform the common substrate (arachidonic acid) to a unique stereo‐ and regiospecific product. Leukotriene synthesis is initiated by 5‐lipoxygenase. Lipoxygenase products and their downstream metabolites are potent signalling molecules, some of which play roles in inflammation or its resolution. Lipoxygenase products are associated with cardiovascular diseases, but their molecular mechanism of action remains unclear.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.